entimo Enters Posit Reseller Agreement
Entimo AG and Posit PBC officially entered a reseller agreement on March 28th, 2024. This enables entimo to provide entimICE FastTrack, the cloud-based Clinical Data Repository and Statistical Computing Environment, in combination with Posit Workbench, Posit Connect and Posit Package Manager as a bundled Software as a Service offer to pharmaceutical, biotech and CRO customers. Entimo AG is known for providing truly language-agnostic and regulatory compliant solutions for clinical data management and statistical analysis to the industry, scaling from biometrics departments of ten members up to data science teams within global enterprises with thousands of users. Posit PBC has taken R, R Shiny and Python to the next level for statistical analysis by providing feature-rich products to manage program development, app deployment, and access and enterprise package management. The bundled offer of entimICE FastTrack and the customer's choice of Posit products provides a cloud-based turnkey solution for regulatory and exploratory analysis in clinical trials.
"We are proud to announce entimo's collaboration with Posit PBC as a trusted software partner. The Posit PBC products are an excellent addition to our portfolio, allowing entimICE users to be even more efficient in their daily work. Posit Workbench offers a powerful alternative to R Studio, for R and Python code development in clinical trials and for exploratory purposes. entimICE FastTrack tightly integrates with Posit Workbench and takes care of regulatory compliance, workflows and end-to-end tracing of all activities within FastTrack and Workbench. The optional usage of Posit Package Manager allows managing package versions and repositories beyond CRAN, enabling statisticians to spend more time on using packages rather than managing packages. The integration of entimICE FastTrack and Posit Connect brings R Shiny apps to the next level in data analysis and visualization, managing the deployment and access to apps and data according to company SOPs and compliance rules. Altogether, the symbiosis of entimICE FastTrack and the Posit PBC products is a big step to foster the use of open-source technologies in clinical trial analysis,” said Marc Jantke, CEO at entimo.
“We are excited to be working with entimo, uniting our expertise with their modern statistical computing environment entimICE FastTrack, which is being used at pharmaceutical and biotech companies of all sizes. Having collaborated for many years, this formal alliance is a natural progression of our relationship. It’s not just about enhancing our product offerings; it’s a commitment to pioneering the future of clinical data science together. We look forward to driving innovation and delivering exceptional value to our customers worldwide through this synergistic partnership. "This partnership will help customers in pharma and biotech, who are ready to embrace open-source solutions in a fully compliant way, to increase their productivity and improve their clinical data analysis workflows,” said Andrea Tharp, Head of Global Channels at Posit PBC.
About Posit PBC
Posit PBC (previously R Studio) was founded in 2009 with the vision of creating high quality open-source software for data scientists. Posit PBC has grown exponentially and invests heavily in open-source development, education, and the community with the goal of serving knowledge creators 100 years from now. Posit PBC's mission is to create open-source software for data science, scientific research, and technical communication. In 2022, R Studio became Posit PBC and released Shiny for Python. Posit PBC provides commercial softwares: Posit Connect, Posit Workbench, and Posit Package Manager and supports more than just R. Over the past few years, Posit PBC has already been investing in other languages like reticulate (calling Python from R), Released the Positron IDE for language agnostic data science, Python features for the IDE, and support for Python and Julia within Quarto.
Visit Posit PBC on the web.
About Entimo
Entimo AG is a life sciences informatics company providing solutions and services to biopharmaceutical and contract research organizations, addressing regulatory requirements in clinical research and development. Entimo AG delivers innovative software solutions and professional services for clinical data and standards management, for statistical analysis and biometrics, and for successful submissions to regulatory authorities. Entimo AG has a track record of matching innovation with reliability since 2003 and serves clients around the globe. In 2021, Entimo AG released its flagship state-of-the-art statistical computing environment entimICE FastTrack on cloud, built on decades-long experience in the pharmaceutical industry, developing high-quality clinical solutions and providing professional services to the market.